March 03, 2021
  • HOME
  • EDUCATION
  • HEALTH
  • PEOPLE
  • SCIENCE
  • TECHNOLOGY
  • HOME
  • EDUCATION
  • HEALTH
  • PEOPLE
  • SCIENCE
  • TECHNOLOGY
Dr Sys Dr Sys
top
Dr Sys
  • HOME
  • EDUCATION
  • HEALTH
  • PEOPLE
  • SCIENCE
  • TECHNOLOGY
Menu
  • HOME
  • EDUCATION
  • HEALTH
  • PEOPLE
  • SCIENCE
  • TECHNOLOGY
loading...
Latest Blogs
  • FDA staff endorses J&J’s single-shot Covid vaccine for emergency use — clearing way for third vaccine in U.S.
  • Crain’s Health Pulse New York: Virtual Reality, Hybrid Instruction Enliven Medical Education During Pandemic
  • New Covid strain leaves UK isolated, with 1,500 trucks stranded at border
  • Google launches knowledge panels in search results to tackle misinformation about Covid vaccines
  • Smell training could help overcome odor distortions after COVID-19, shows study
  • Pfizer and BioNTech to request emergency authorization from FDA for Covid vaccine
  • Moderna says preliminary trial data shows its coronavirus vaccine is more than 94% effective, shares soar
  • Rural areas have fewer mental health services for young people, but great need
  • Acupuncture before surgery may reduce pain, opioid use
  • Medical myths: Mental health misconceptions
Home Covid vaccine
FDA staff endorses J&J’s single-shot Covid vaccine for emergency use — clearing way for third vaccine in U.S.

FDA staff endorses J&J’s single-shot Covid vaccine for emergency use — clearing way for third vaccine in U.S.

Posted By: Editorial Teamon: February 24, 2021In: HEALTH, SCIENCENo Comments

The Food and Drug Administration’s staff endorsed Johnson & Johnson’s Covid-19 vaccine for emergency use, a critical step in bringing a third shot to the U.S. marketplace. The staff report released Wednesday is meant to brief the FDA’s Vaccines and Related Biological Products Advisory Committee, which will meet Friday to review J&J’s request for emergency use authorization. During […] Read more

Share 0
Tweet
Share
Share
Share
Pfizer and BioNTech to request emergency authorization from FDA for Covid vaccine

Pfizer and BioNTech to request emergency authorization from FDA for Covid vaccine

Posted By: Editorial Teamon: November 20, 2020In: HEALTH, SCIENCE, TECHNOLOGYNo Comments

Pfizer and BioNTech will apply Friday for an emergency use authorization from the Food and Drug Administration for their coronavirus vaccine. If Pfizer’s application is approved, the vaccine will likely be limited and rolled out in phases, with health-care workers, the elderly and people with underlying health conditions getting the first inoculations. Essential workers, teachers and people in […] Read more

Share 0
Tweet
Share
Share
Share

Advertising

services
solutions
vrp

2018 Powered By GroupW

  • HOME
  • EDUCATION
  • HEALTH
  • PEOPLE
  • SCIENCE
  • TECHNOLOGY